Feb 23: AstraZeneca settles £505m tax row

AstraZeneca, the Anglo-Swedish drugs group, will pay £505m to settle a long-running dispute with the UK tax authorities over the contentious issue of transfer pricing. Andrew Jack, pharmaceuticals correspondent, talks to Daniel Garrahan about what the dispute is about and the implications for other companies.